Advertisement
GRI 外匯新聞
GRI Bio Says FDA Clears IND For GRI-0621 For Treatment Of IPF; Stock Up 19%
Biotechnology company GRI Bio, Inc. (GRI) announced Monday that the U.S. Food and Drug Administration has cleared the Company's Investigational New Drug (IND) application for GRI-0621 for the treatment of IPF.
RTTNews
|
575天前
